Institutional investors hold a majority ownership of PCRX through the 116.58% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2015, these large investors purchased a net $10.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VISIUM ASSET MANAGEMENT LP Bought 2.3 Million shares of Pacira Pharmaceuticals In...